Trial Outcomes & Findings for Electrical Stimulation to Accelerate Wound Healing (NCT NCT03821675)

NCT ID: NCT03821675

Last Updated: 2022-05-09

Results Overview

Lower-extremity skin perfusion will be assessed using a skin perfusion pressure device (PADIQ Sensilase). This device emerges pressure with a cuff placed around the calf muscle that has internal sensors. Then, the cuff is slowly released letting circulation to re-enter which is detected by the sensors.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

38 participants

Primary outcome timeframe

Change at 4 weeks from baseline.

Results posted on

2022-05-09

Participant Flow

Participant milestones

Participant milestones
Measure
Active
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Sham
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Overall Study
STARTED
19
19
Overall Study
COMPLETED
16
17
Overall Study
NOT COMPLETED
3
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Electrical Stimulation to Accelerate Wound Healing

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active
n=16 Participants
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Sham
n=17 Participants
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Total
n=33 Participants
Total of all reporting groups
Age, Continuous
65.1 years
STANDARD_DEVIATION 13.8 • n=5 Participants
61.4 years
STANDARD_DEVIATION 11.2 • n=7 Participants
63.2 years
STANDARD_DEVIATION 8.3 • n=5 Participants
Sex: Female, Male
Female
6 Participants
n=5 Participants
6 Participants
n=7 Participants
12 Participants
n=5 Participants
Sex: Female, Male
Male
10 Participants
n=5 Participants
11 Participants
n=7 Participants
21 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
7 Participants
n=5 Participants
5 Participants
n=7 Participants
12 Participants
n=5 Participants
Race (NIH/OMB)
White
9 Participants
n=5 Participants
12 Participants
n=7 Participants
21 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Change at 4 weeks from baseline.

Lower-extremity skin perfusion will be assessed using a skin perfusion pressure device (PADIQ Sensilase). This device emerges pressure with a cuff placed around the calf muscle that has internal sensors. Then, the cuff is slowly released letting circulation to re-enter which is detected by the sensors.

Outcome measures

Outcome measures
Measure
Active
n=16 Participants
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Sham
n=17 Participants
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Change in Skin Perfusion in Response to Electrical Stimulation Therapy
65.1 mmHg
Standard Deviation 19.1
72.2 mmHg
Standard Deviation 18.1

PRIMARY outcome

Timeframe: Change at 4 weeks from baseline

Wound size will be assessed with a Sillouette Star 3D Camera that detects width, length, and depth of wounds that automatically gives you a cm2 area.

Outcome measures

Outcome measures
Measure
Active
n=16 Participants
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Sham
n=17 Participants
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Change in Wound Size in Response to Electrical Stimulation Therapy
5.8 cm2
Standard Deviation 8
3.2 cm2
Standard Deviation 8.7

SECONDARY outcome

Timeframe: Change at 4 weeks from baseline.

change in plantar sensation will be assessed with a vibration pressure threshold device placed on the heel.

Outcome measures

Outcome measures
Measure
Active
n=16 Participants
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Sham
n=17 Participants
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Change in Plantar Sensation in Response to Electrical Stimulation
20.2 Volts
Standard Deviation 14
32.1 Volts
Standard Deviation 9.2

SECONDARY outcome

Timeframe: Change at 60 minutes from baseline.

Population: Active electrical stimulation was performed during one hour on all participants before randomization.

Plantar tissue oxygen saturation will be assessed with Near infrared Spectroscopy device (KENT Imaging) at 60 minutes from baseline.

Outcome measures

Outcome measures
Measure
Active
n=38 Participants
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Sham
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Change From Baseline to 60 Minutes in Tissue Oxygen Saturation in Response to Electrical Stimulation
73.5 SatO2%
Standard Deviation 12.5

SECONDARY outcome

Timeframe: Change at 4 weeks from baseline.

Plantar tissue oxygen saturation will be assessed with Near infrared Spectroscopy device (KENT Imaging)

Outcome measures

Outcome measures
Measure
Active
n=16 Participants
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Sham
n=17 Participants
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Change in Tissue Oxygen Saturation in Response to Electrical Stimulation
72.3 SatO2%
Standard Deviation 21.5
73.9 SatO2%
Standard Deviation 12.1

OTHER_PRE_SPECIFIED outcome

Timeframe: an average of 60 minutes from baseline

Population: Active electrical stimulation was performed during one hour on all participants before randomization.

Lower-extremity skin perfusion will be assessed using a skin perfusion pressure device (PADIQ Sensilase). This device emerges pressure with a cuff placed around the calf muscle that has internal sensors. Then, the cuff is slowly released letting circulation to re-enter which is detected by the sensors.

Outcome measures

Outcome measures
Measure
Active
n=38 Participants
Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks.
Sham
Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks.
Change From Baseline in Skin Perfusion in Response to Electrical Stimulation
79.9 mmHg
Standard Deviation 18.3

Adverse Events

Active

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sham

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Prof. Bijan Najafi

Baylor College of Medicine

Phone: 17137987536

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60